Nerve-sparing techniques in prostate cancer surgery
Part of Cancer, Kidney & urinary clinical trials.
This trial compares two nerve-sparing techniques during robotic prostatectomy to see which better preserves urinary and sexual function while still effectively removing the cancer. It is for men with early-stage, favorable-risk prostate cancer who are good surgical candidates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 80 years old.
- You have prostate cancer that is considered very low, low, or intermediate risk (not high risk or advanced).
- Your cancer has not spread outside the prostate capsule (no stage T3 or higher) and no signs of spread to lymph nodes or bones on imaging.
- You are in good overall health (ECOG performance status 0 or 1) and expected to live more than 10 years.
- You have not had any previous treatment for prostate cancer (like surgery, radiation, hormones, or chemotherapy) and are not currently on hormone therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your health before surgery affects your erectile function after robot-assisted prostate removal. It aims to help doctors predict and improve recovery of erectile function.
This study looks at a robotic prostate operation that aims to remove only the affected side while keeping the urethra (the tube for urination) to help preserve urinary function. It’s for people with low- to intermediate-risk, one-sided prostate cancer and no spread to lymph nodes, bones, or other organs.
This trial tests if a nerve grafting technique can help preserve erectile function after robotic surgery for high-risk localized prostate cancer. It may be an option for men with good preoperative erectile function.
This study tests whether using a special ultrasound tool during prostate cancer surgery helps protect the nerves that control erections. If you have good erectile function and are scheduled for nerve-sparing prostate removal, this trial may be a good fit for you.
This early-stage trial tests a treatment designed to protect nerves during prostate removal surgery for cancer. The goal is to help patients recover sexual function after surgery, which is a common concern.
This trial tests a new way to rebuild the urethra during robot-assisted prostate removal surgery for prostate cancer. It may help people whose cancer hasn't spread too far or has been reduced enough for surgery.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.